Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$6.2M
1 round on record
Latest round
$6.2M
Venture round · Jul 2026 · 2 mo ago
Team
11-50
employees, estimated range
Backers
1
50 Partners
The money's age
Fresh money
2 months since the last round · not hiring
Momentum
35/100
in the news, fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 13 Raised a round Venture round $6.2M · led by Blue Forest Ventures · YahooFinance
Funding rounds
RoundDateAmountInvestorsSource
Venture round Jul 2026 $6.2M Blue Forest Ventures lead YahooFinance
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Age LabsFounded 2017 • 11-50 employees
Age Labs is a Norwegian life science company that discovers, develops and commercializes diagnostic tests for the early detection of…
AmplifiDxVenture round $329k · 5 yr ago • Founded 2020
The Might of Molecular. Fast & Accurate Results*.
AbionicVenture round $21M · 8 yr ago • 51-200 employees
Home About Us About us Abionic, an emerging medical diagnostics company focused on rapid early detection technologies, received 510(k)…
SIGNATUR BIO51-200 employees
Expanding PCR testing to a whole new range of conditions. Making precision diagnostics accessible around the planet. Our technology…
QSM DiagnosticsVenture round $25k · 6 yr ago • 201-500 employees
Products for veterinarians. Diagnostic mail-in test kits and instruments for cats and dogs. Cytology, urinalysis, fecal, culture &…
Scanbase makes it easy to convert photos of rapid diagnostic tests into positive or negative results.

Overview

En Carta Diagnostics develops molecular tests, as easy to use as rapid tests, as precise as a PCR machine. We currently offer Lyme disease early detection kits and CT/NG - Chlamydia and Gonorrhea kits.

News

News YahooFinance 3 months ago
En Carta secures $6.18m to expand molecular testing solutions
The funding comprises €3m in equity led by Blue Forest Ventures, and €2m in non-dilutive funding.
Read more
Report
News Pulse 2.0 3 months ago
En Carta Diagnostics Raises €5 Million To Advance At-Home Molecular Diagnostics Platform
En Carta Diagnostics announced a €5 million funding round to advance its molecular diagnostics platform and support its commercial launch. The round combines investment led by Blue Forest Ventures, participation from Ring Capital, and support from existin
Read more
Report

Financials

Total raised
$6.2M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2026 $6.2M Details